BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Antisense Therapeutics Limited 

Level 1
10 Wallace Avenue
Toorak  Victoria  3142  Australia
Phone: 61-3-9827-8999 Fax: 61-3-9827-1166


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS Further Development Plans – U.S. FDA Pre-IND Response Timing Confirmed; European Patent Allowance 9/16/2014 3:02:34 PM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1103 Phase 2 Trial - Successful Efficacy Results 9/3/2014 11:21:14 AM
Antisense Therapeutics Limited (ANP.AX) Release: Strategy Update - ATL1103 & ATL1102 8/20/2014 9:11:33 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1103 Acromegaly Phase 2 Trial Dosing Completed 7/29/2014 7:45:31 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Toxicology Study Main Findings 4/1/2014 9:00:25 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1103 Acromegaly Phase 2 Trial Recruitment Completed 3/21/2014 10:43:28 AM
Antisense Therapeutics Limited (ANP.AX) Selected To Present At Biotech Showcase™ 2014 1/8/2014 6:51:53 AM
Antisense Therapeutics Limited (ANP.AX) Release: Positive Results Achieved From Interim Analysis Of ATL1103 Phase II Trial 12/23/2013 9:31:41 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 for Multiple Sclerosis -Toxicology Study to Commence 5/2/2013 1:42:18 PM
Antisense Therapeutics Limited (ANP.AX) and TJAB Advance MS Drug 3/19/2013 2:45:04 PM
1234